4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-17-019314
Director sold 17,471 shares at an average $40.33 ($704,519)
- Director acquired 17,471 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
MERRIMAN RONALD · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-05-22 | Exercise or conversion : show line 1 in the form | +7,118 | $34.41 | $244,895 | 24,925 | D |
| 2017-05-22 | Sale : show line 2 in the form | −7,118 | $40.31 | $286,917 | 17,807 | D |
| 2017-05-22 | Exercise or conversion : show line 3 in the form | +10,353 | $30.50 | $315,792 | 28,160 | D |
| 2017-05-22 | Sale : show line 4 in the form | −10,353 | $40.34 | $417,602 | 17,807 | D |
| Open-market sales · 17,471 sh · avg $40.33 · $704,519 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-05-22 | Exercise or conversion : show line 5 in the form Non-qualified Stock Option (Right to Buy) | −7,118 | 0 | D |
| 2017-05-22 | Exercise or conversion : show line 6 in the form Non-qualified Stock Option (Right to Buy) | −10,353 | 0 | D |
Loading xslF345X03/form4.xml…